ABSTRACT: Humans and other mammals are colonized by trillions of microorganisms, most of which reside in the gastrointestinal tract, that provide key metabolic capabilities, such as the biosynthesis of vitamins and AA, the degradation of dietary plant polysaccharides, and the metabolism of orally administered therapeutics. Although much progress has been made by studying the human microbiome directly, comparing the human microbiome with that of other animals, and constructing in vitro models of the human gut, there remains a need to develop in vivo models where host, microbial, and environmental parameters can be manipulated. Here, we discuss some of the initial results from a promising method that enables the direct manipulation of microbial community structure, environmental exposures, host genotype, and other factors: the colonization of germ-free animals with complex microbial communities, including those from humans or other animal donors. Analyses of these resulting "humanized" gut microbiomes have begun to reveal 1) that key microbial activities can be transferred from the donor to the recipient animal (e.g., microbial reduction of cholesterol and production of equol), 2) that dietary shifts can affect the composition, gene abundance, and gene expression of the gut microbiome, 3) the succession of the microbial community in infants and ex-germ-free adult animals, and 4) the biogeography of these microbes across the length of gastrointestinal tract. Continued studies of humanized and other intentionally colonized animal models stand to provide new insight into not only the human microbiome, but also the microbiomes of our animal companions.
INTRODUCTION
It is currently estimated that the human gastrointestinal tract harbors between 10 13 and 10 14 microorganisms (i.e., the gut microbiota) and that the total number of microbial cells in each individual outnumbers their mammalian cells by an order of magnitude (Hooper and Gordon, 2001; Turnbaugh et al., 2007) . The aggregate genomes of the microbes found in the human gut contain an extensive catalog of genes and are collectively referred to as the gut microbiome. The human gut microbiome displays a large degree of interindividual variation; each person harbors a distinctive collection of abundant bacterial species, although the fecal microbiomes of monozygotic and dizygotic cotwins are more similar to each other, and to those of their mothers, than to the microbiomes of unrelated individuals (Turnbaugh et al., 2009a (Turnbaugh et al., , 2010 . Despite these variations in the specific bacterial strains or species found, the gut microbiome contains a core set of genes and gene families representing key metabolic functions (Turnbaugh et al., 2009a; Qin et al., 2010) . These functions include the ability to synthesize essential AA, vitamins, and isoprenoids, along with a diverse array of carbohydrate-active enzymes enabling the degradation of host and dietary polysaccharides (Gill et al., 2006) .
The human gut microbiome has been implicated in multiple human diseases, including metabolic syndrome Wen et al., 2008; Vijay-Kumar et al., 2010) , inflammatory bowel disease (Mazmanian et al., 2008; Cadwell et al., 2010) , and peptic ulcers (Marshall, 2003) . Additionally, the gut microbiota have been found to subject pharmaceuticals and other xenobiotics to numerous chemical processes, including reduction, hydrolysis, dehydroxylation, acetylation, deacetylation, and proteolysis, among others (Sousa et al., 2008) . The microbial metabolism of xenobiotics by gut microbes can alter their pharmacokinetics or bioavailability, resulting in an inappropriate dose or the production of toxic metabolites (Sousa et al., 2008) . Additionally, variation in the metabolic activity of the gut microbiome may indirectly influence the metabolism of rapidly absorbed drugs, such as the widely used acetominophen (also referred to as paracetamol; Clayton et al., 2009) .
Because the human microbiome has the potential to affect so many aspects of human health, it has recently become the focus of a series of international human microbiome projects (Turnbaugh et al., 2007; Nelson et al., 2010; Qin et al., 2010) . These efforts are harnessing the falling costs and increasing throughput of DNA sequencing to characterize the organisms, genes, and functional capacities found in microbial communities across many diverse body habitats (Turnbaugh et al., 2007) . Figure 1a depicts an example of a pipeline for the metagenomic analysis of animal-associated microbial communities. The use of culture-independent methods avoids the biases introduced by the differing ability of gut microbes to thrive when isolated in culture. Metagenomic analysis of the human microbiome has already yielded a tremendous volume of sequencing data, establishing a catalog of genes from 124 unrelated individuals (Qin et al., 2010) and 178 (soon to be nearly 1,000) genomes from multiple body habitats (Nelson et al., 2010) . However, many questions remain regarding the environmental and host factors that govern microbial community structure and function, the role the human microbiome plays in health and disease, and the best methods of manipulating such a complex and dynamic ecosystem.
Studies of the gut microbiomes of human populations, although informative, are confounded by several factors that are difficult or impossible to control at the present time. These include 1) variation in human genotypes, 2) large interindividual variation in the bacterial species found in the gut of each individual, and 3) current and past environmental exposures. Dietary macro-and micronutrient composition and caloric load, in particular, are hard to control or even adequately monitor in human cohorts without studying individuals residing within an inpatient medical facility. Together, these factors complicate ongoing efforts to disentangle the complex connections between diet, the structure and function of the gut microbiota, and human pathophysiology.
Animal models provide the ability to control many of the factors mentioned above, providing a step toward a mechanistic understanding of host-microbial interactions, and potentially allowing the rational design of future human studies. To date, the gut microbiomes of multiple animals have been surveyed, including but not limited to, a selection of animals throughout the mammalian phylogeny , mice (Ley et al., 2005) , healthy adult dogs (Middelbos et al., 2010) , chickens (Qu et al., 2008) , and cows (Brulc et al., 2009 ). These studies have emphasized the critical role of host diet in shaping microbial community structure: bacterial diversity increases from carnivory to omnivory to herbivory , and the supplementation of the canine diet with dietary fiber affects the Firmicutes phylum of bacteria (Middelbos et al., 2010) . Additionally, the same dominant bacterial phyla have been found across a wide range of mammals, including Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria, indicating that some features of the gut microbiome are conserved.
Despite these high-level similarities, the gut microbiota can differ greatly between animals; for example, many of the species and genera of bacteria found in mice are not present in humans (Ley et al., 2005) , limiting the ability to directly extrapolate from conventionally raised mice to humans. One solution to this problem is to colonize a germ-free animal with a complex microbial consortium, such as those obtained from a human donor or from another animal. Combining this technique with the use of specific familial lineages or inbred strains and the husbandry techniques of a modern biological animal facility affords a strong framework to study human microbes in vivo under controlled conditions, although alternative methods using in vitro model gut systems provide a complementary and informative approach (Kovatcheva-Datchary et al., 2009) . Future studies of this kind promise to lend new insight into the human microbiome and into the microbiomes of many other animals of interest.
RECIPROCAL TRANSPLANTATION OF THE ZEBRAFISH AND MOUSE GUT MICROBIOTA
Zebrafish are frequently used to study developmental biology and genetics, and they provide distinctive advantages relative to other animal models with regard to the study of the human gut microbiome. First, they are transparent until adulthood, allowing real-time visualization of fluorescently labeled microbes throughout the gut (Rawls et al., 2007) . Second, chemical screens and forward genetic tests can be performed (Patton and Zon, 2001 ) for purposes such as investigating host genes or signaling pathways that are regulated by members of the gut microbiota.
To explore the establishment of a gut microbiota in germ-free animals, a series of reciprocal microbiota transplantation experiments were performed between conventionally raised mouse and zebrafish donors, and germ-free mouse and zebrafish recipients (Rawls et al., 2006) . These studies represented an initial attempt to address several critical questions related to host and microbial co-evolution. For example, how restricted are the relationships between bacterial and host species? Are some "cosmopolitan" bacteria able to colonize a wide range of hosts? Are other bacteria restricted to one metazoan species? What factors determine which bacteria successfully colonize a germ-free animal, and how are these initial populations shaped upon colonization?
The analysis of 16S rRNA gene sequences generated from total community DNA isolated from the gut of conventionally raised zebrafish and mice revealed that although the mouse microbiota resembles the human microbiota (i.e., dominated by the bacterial phyla Firmicutes and Bacteroidetes), the zebrafish microbiota is predominantly Proteobacteria and Fusobacteria. After transplantation, the species found in each recipient animal resembled the donor microbiota, but the relative abundance of each taxonomic group was altered to more closely resemble the typical microbiota of the recipient; germ-free mice colonized with a zebrafish sample had an increased relative abundance of Firmicutes, whereas germ-free zebrafish colonized with a mouse sample had an increased relative abundance of Proteobacteria (Rawls et al., 2006) . These observations are consistent with the idea that a currently ill-defined collection of selection pressures in each host acts to influence community structure during or after colonization. Together, these results provide an important precedent for future microbiota transplantations within and between diverse metazoan species.
HUMANIZATION OF RATS AND PIGS
"Humanized" animals have been established by multiple groups in an attempt to study the human microbiome under controlled conditions, utilizing well-studied and genetically manipulable mice and rats, in addition to pigs (Hazenberg et al., 1981; Hirayama, 1999; Bowey et al., 2003; Gérard et al., 2004; Kibe et al., 2005; Pang et al., 2007) . Figure 1b represents a schematic of the humanization procedure and some examples of followup experiments. These studies have already begun to reveal novel aspects of the human microbiome, including the production of equol from dietary soy-isoflavones (Bowey et al., 2003) , the microbial reduction of cholesterol (Gérard et al., 2004) , and microbial succession during weaning in piglets (Pang et al., 2007) .
Germ-free rats and those colonized with a human fecal microbiota have been used to investigate the microbial production of equol, a metabolite with a proposed protective effect against cancer, from a soy-isoflavone containing diet (Bowey et al., 2003) . Humans vary in their ability to produce equol from daidzein, a soy-isoflavone, and this ability was shown to be transmissible to germ-free rat recipients. Germ-free rats colonized with a fecal sample from a greater equol-producing human donor excreted significant amounts of equol, whereas rats colonized with a fecal sample from a lesser equol-producing donor had no detectable equol in their urine (Bowey et al., 2003) .
Rats have also been used to investigate the microbial reduction of cholesterol to coprostanol in the human gut. The clearance of the poorly absorbed coprostanol is one potential pathway for the elimination of cholesterol (Gérard et al., 2004) . Humanized rats had a "coprostanoligenic" bacterial load and activity similar to those of the corresponding human donor (greater or lesser coprostanol-producing). Culture-independent methods (hybridization with fluorescently labeled oligonucleotide probes targeting the 16S rRNA and temporal temperature gradient gel electrophoresis of bacterial 16S rRNA gene amplicons) revealed that humanized rats maintained a stable microbial community similar to the human donor microbiota (Gérard et al., 2004) .
Pigs have been proposed as an attractive model for studying the human gut microbiome: their diet is omnivorous and their digestive tract shares many anatomical and physiological traits with that of humans. Furthermore, a recent study demonstrated the ability to create humanized pigs (Pang et al., 2007) . The investigators delivered piglets by cesarean section into a specific-pathogen-free barrier system and then introduced a human microbiota by oral gavage of a fecal suspension collected from a healthy 10-yr-old boy. The culture-independent analysis of the gut microbiota of the recipient pigs and that of the human donor revealed that transplantation of the gut microbiota from a human to germ-free piglets resulted in a microbial community similar to the human donor, with minimal individual variation between pigs. As in humans, the introduction of solid food during weaning altered the gut microbial community, resulting in a decrease in Bifidobacteria (Pang et al., 2007) . These studies demonstrate that the process of microbial colonization shares some similarities between animals and provide an attractive model to explore the effect of dietary or other environmental perturbations on the establishment of the gut microbiota.
METAGENOMIC ANALYSIS OF HUMANIZED MICE
Mice are by and large the most widely used germfree animal model and have numerous advantages as a model organism, including the availability of genetically modified inbred lines, the ease of animal husbandry, and their many similarities to human physiology and genetics. In our recent studies, we have applied metagenomic methods to analyze a humanized mouse model (Turnbaugh et al., 2009b) . We colonized germ-free C57BL/6J mice via gavage with a fecal suspension from an anonymous human donor. Barcoded pyrosequencing of the variable region 2 (V2) of the 16S rRNA gene revealed that 1) the donor community was reproducibly transferred to the germ-free mouse recipients, 2) this community was relatively stable over time when recipient mice were maintained on a standard low-fat, plant polysaccharide-rich diet (LF/PP; Figure 2) , and 3) the human microbiota could be transferred to additional generations through gavage or co-housing. Surprisingly, inoculation with a frozen human fecal sample stored at −80°C for over a year resulted in the establishment of a similar gut microbiota in recipient mice, raising the possibility of collecting human fecal samples from more remote locations and freezing them for later analysis in germ-free mice (Turnbaugh et al., 2009b) .
Humanized mice (H-Mice) were then used to investigate the effects of a defined diet change on gut microbial community structure. All H-Mice were maintained on the LF/PP diet until 1 mo after humanization, at which time half of the H-Mice were switched to an high-fat, high-sugar Western diet. All animals were maintained on their respective diets for 2 mo with weekly fecal sampling to allow for time series analyses of microbial community composition based on sequencing the V2 region of the 16S rRNA gene. We observed that the gut microbiota rapidly reconfigured upon a shift in diet; clear changes were observed after a single day on the Western diet. Relative to H-Mice on the LF/ PP diet, animals fed the Western diet had a greater relative abundance of the Erysipelotrichi and Bacilli classes of the bacterial Firmicutes phylum and a decreased abundance of the Bacteroidetes phylum ( Figure  2 ). In addition, reciprocal transplantations between donor and recipient H-Mice fed the LF/PP and Western diet demonstrated that microbial community structure rapidly conforms to the diet of the recipient animal, regardless of the diet of the donor (Turnbaugh et al., 2009b) .
Diet-associated changes in the gene content of the microbiome were assessed by shotgun sequencing community DNA isolated from H-Mice at multiple time points before and after the diet switch. As was the case for the relative abundance of bacterial taxonomic groups, the distribution of genes found within the microbiome shifted after only 1 d on the Western diet. The Western diet-associated microbiome was enriched for several KEGG (Kyoto Encyclopedia for Genes and Genomes) metabolic pathways, including those for ATP-binding cassette (ABC) transporters and phosphotransferase systems (PTS), which are both involved in the import and metabolism of carbohydrates. The specific ABC transporters identified included ones with predicted roles in sugar, AA, and cofactor import and the PTS included predicted transporters for fructose, N-acetylgalactosamine, cellobiose, and mannose. The microbiomes of LF/PP mice had an increased representation of pathways that are also enriched in draft genomes from the Bacteroidetes phylum (Turnbaugh et al., 2009a) , including N-glycan degradation, sphingolipid metabolism, and glycosaminoglycan degradation. These findings correspond with the increased relative abundance of phylum Bacteroidetes in LF/PP mice (Turnbaugh et al., 2009b) .
We next turned to a recently developed set of techniques, termed metatranscriptomics, with the goal of analyzing the transcriptional activity of the gut microbiome (Frias-Lopez et al., 2008; Rey et al., 2010; Stewart et al., 2010; Turnbaugh et al., 2010) . Before these analyses, a novel isolate representative of the bacterial species found at greater abundance on the Western diet (Clostridium innocuum strain SB23) was cultured from a humanized mouse cecal sample and subjected to whole-genome shotgun sequencing, revealing a diverse array of predicted PTS, ABC transporters, and carbohydrate-active enzymes. Metatranscriptomics was then applied to samples taken from the cecum of mice fed the LF/PP and Western diet. As had been observed previously for community structure and gene content, the characterized metatranscriptomes clustered according to diet, when considering gene expression across the entire community or solely the gene expression of C. innocuum strain SB23. A total of 69 genes in the SB23 genome were significantly upregulated on the Western diet, including key genes predicted to be involved in carbohydrate transport and metabolism; these trends were subsequently validated by quantitative reversetranscription PCR. After widening the search to look for genes differentially expressed across the metatranscriptome, a total of 520 clusters of genes were identified as being differentially expressed between the 2 diets (Turnbaugh et al., 2009b) .
Microbiota transplantation experiments utilizing genetically obese ob/ob mice , conventionally raised C57BL/6J mice fed a Western diet , and mice lacking the Tolllike receptor 5 (Vijay-Kumar et al., 2010) have demonstrated that colonization with an obesity-associated gut microbiome results in an increased gain in adiposity relative to colonization with a gut microbiome harvested from lean controls. These results are consistent with experiments in H-Mice; germ-free mice colonized with a community harvested from a humanized donor on the Western diet had a significantly greater increase in total body fat over 2 wk than those colonized with a sample from a donor fed the LF/PP diet. This change in adiposity occurred even though there was no significant difference in chow consumption between the 2 groups of recipient mice and the 2 groups of recipients were matched at the start of the experiment for age, BW, and body fat (Turnbaugh et al., 2009b) .
The use of humanized animal models also permitted the characterization of the biogeography and assembly of the gut microbiota. We surveyed the gut microbiota throughout the stomach, small intestine, cecum, colon, and feces. The proportional representation of Bacteroidetes increased remarkably during intestinal transit, with this phylum accounting for, on average, 14% of the microbiota in the small intestine and 42% throughout the cecum, colon, and feces. In a similar pattern, overall bacterial diversity also increased as one traveled distally in the gut. Diet influenced community structure along the entire length of the gut, with Western-fed mice displaying increased presence of the Erysipelotrichi and Bacilli classes. Additionally, time-series analysis of the fecal microbiota of H-Mice beginning at postnatal d 14 revealed an increase in bacterial diversity from d 14 to 24, accompanied by a decrease in Proteobacteria and an increase in the Bacteroidetes upon weaning onto solid foods (Turnbaugh et al., 2009b) .
SUMMARY AND CONCLUSIONS
To date, these initial studies of humanized animal models have allowed a view of the human microbiome that would be difficult to achieve using traditional human cohort studies or in vitro model systems. Studies of humanized mice consuming a low-fat, plant polysaccharide-rich or high-fat, high-sugar Western diet have demonstrated that dietary shifts can have major and rapid effects on the gut microbiome (Turnbaugh et al., 2009b) . These animals will likely provide a critical tool to help understand the interaction between diet and microbial community structure and function, leading to follow-up studies in humans with study designs where diet exposures do not have to be prolonged.
Studies of humanized rats have provided a critical proof-of-principle: in addition to transferring gut microbes between humans and germ-free animals, the humanization process maintains at least some of the interesting metabolic activities, such as the production of equol (Bowey et al., 2003) or the reduction of cholesterol (Gérard et al., 2004 ). The resulting animals could then be used to investigate the biogeography and mechanism of these functions or to propagate and enrich for microbes of interest in vivo.
The observation that frozen human fecal samples can be used to colonize germ-free animals (Turnbaugh et al., 2009b) opens new possibilities for coupling surveys of the human microbiome with in vivo functional assays. For example, fecal samples could be collected from lean and obese humans, or individuals suffering from inflammatory bowel disease and healthy controls, and then used to colonize wildtype or genetically susceptible germ-free recipients. These types of studies, coupled with mass spectrometry, detailed host phenotyping, transcriptomics, and bacterial genetics, are necessary to better understand the microbial triggers of disease at a molecular level.
Although much of the research to date has focused on the human microbiome, similar metagenomic methods coupled to studies of germ-free and colonized animal models could be applied to better understand many animals of agricultural or personal interest, ranging from dogs and cats to pigs and chickens. These interspecies microbiota transplantation experiments stand to provide new information regarding the host specificity of the microbiome and promise to shed new light on the diversity and function of a wide range of microbiomes.
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